BioNTech SE (BNTX) EBT (2018 - 2025)

BioNTech SE has disclosed EBT across 8 years of filings, most recently posting -$264.7 million for Q4 2025.

• EBT for Q4 2025 came in at -$264.7 million, down 182.24% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.2 billion (down 58.48% YoY), and the FY2025 annual result was -$1.2 billion, down 63.94% from the prior year.
• EBT came in at -$264.7 million for Q4 2025 at BioNTech SE, down from $28.9 million in the prior quarter.
• In the past five years, EBT ranged from a high of $5.6 billion in Q1 2022 to a low of -$867.8 million in Q2 2024.
• The 5-year median for EBT is $517.7 million (2023), against an average of $1.5 billion.
• Across the five-year window, EBT soared 2199836406.41% in 2021 and sank 182.24% in 2025, its largest moves.
• BioNTech SE's EBT stood at $5.4 billion in 2021, then slumped by 39.98% to $3.2 billion in 2022, then slumped by 77.95% to $713.6 million in 2023, then sank by 54.89% to $321.9 million in 2024, then tumbled by 182.24% to -$264.7 million in 2025.
• The last three EBT figures came in at -$264.7 million (Q4 2025), $28.9 million (Q3 2025), and -$455.8 million (Q2 2025), per Business Quant data.